Nurkka A - Search Results

1

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.

Nurkka A, Ahman H, Yaich M, Eskola J, Käyhty H. Nurkka A, et al. Vaccine. 2001 Oct 12;20(1-2):194-201. doi: 10.1016/s0264-410x(01)00250-x. Vaccine. 2001. PMID: 11567764 Clinical Trial.

2

Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu A, Käyhty H; FinOM Study Group. Nurkka A, et al. Vaccine. 2004 Dec 2;23(3):298-304. doi: 10.1016/j.vaccine.2004.06.009. Vaccine. 2004. PMID: 15530671 Clinical Trial.

3

Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Ekström N, Givon-Lavi N, Käyhty H, Dagan R. Simell B, et al. Among authors: nurkka a. Clin Vaccine Immunol. 2012 Oct;19(10):1618-23. doi: 10.1128/CVI.00248-12. Epub 2012 Aug 8. Clin Vaccine Immunol. 2012. PMID: 22875604 Free PMC article.

4

Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.

Nurkka A, MacLennan J, Jäntti V, Obaro S, Greenwood B, Käyhty H. Nurkka A, et al. Vaccine. 2000 Oct 15;19(4-5):547-56. doi: 10.1016/s0264-410x(00)00180-8. Vaccine. 2000. PMID: 11027820

5

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

Nurkka A, Ahman H, Korkeila M, Jäntti V, Käyhty H, Eskola J. Nurkka A, et al. Pediatr Infect Dis J. 2001 Jan;20(1):25-33. doi: 10.1097/00006454-200101000-00006. Pediatr Infect Dis J. 2001. PMID: 11176563

6

Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants.

Nurkka A, Joensuu J, Henckaerts I, Peeters P, Poolman J, Kilpi T, Käyhty H. Nurkka A, et al. Pediatr Infect Dis J. 2004 Nov;23(11):1008-14. doi: 10.1097/01.inf.0000143640.03214.18. Pediatr Infect Dis J. 2004. PMID: 15545855 Clinical Trial.

7

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Nurkka A, Lahdenkari M, Palmu AA, Käyhty H; FinOM Study Group. Nurkka A, et al. BMC Infect Dis. 2005 May 27;5:41. doi: 10.1186/1471-2334-5-41. BMC Infect Dis. 2005. PMID: 15921511 Free PMC article. Clinical Trial.

8

Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.

Poolman J, Frasch C, Nurkka A, Käyhty H, Biemans R, Schuerman L. Poolman J, et al. Among authors: nurkka a. Clin Vaccine Immunol. 2011 Feb;18(2):327-36. doi: 10.1128/CVI.00402-10. Epub 2010 Dec 1. Clin Vaccine Immunol. 2011. PMID: 21123523 Free PMC article.

9

Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.

Simell B, Nurkka A, Lahdenkari M, Givon-Lavi N, Käyhty H, Dagan R, Jokinen J. Simell B, et al. Among authors: nurkka a. Clin Vaccine Immunol. 2012 Jan;19(1):96-9. doi: 10.1128/CVI.05369-11. Epub 2011 Nov 9. Clin Vaccine Immunol. 2012. PMID: 22072724 Free PMC article.

10

Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva.

Nurkka A, Obiero J, Käyhty H, Scott JA. Nurkka A, et al. Clin Diagn Lab Immunol. 2003 May;10(3):357-61. doi: 10.1128/cdli.10.3.357-361.2003. Clin Diagn Lab Immunol. 2003. PMID: 12738631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters